Delivery Order SPE2DB22D2006-SPE2DB24FW2ZH

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $122K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceuticals. The contract has a potential value of $2,539.62 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there was no set-aside designation used for this award. This delivery order is part of a larger...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $116,040.40 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceuticals with a performance period through March 15, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $4,628.05 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,655.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S and has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp by DLA,...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,418.70, is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of January 27, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $102,868.93 firm-fixed-price delivery order contract for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $50,371.20 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML medical products, with a completion date of January 14, 2025. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a ceiling value of $3,795.35 and a performance period through May 28, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products, with a firm fixed price of $4,823.16 and a completion date of February 26, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, as a prime contractor, has an indefinite delivery contract (IDC)...
This contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,030.65 firm fixed-price order is for the medical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2ZH
    Delivery Order

The Defense Logistics Agency (DLA) Troop Support Medical awarded a $121,770.00 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 20, 2024 and does not utilize a set-aside designation.

Generated 11/18/24, 9:44 AM